Proactive Investors - Run By Investors For Investors

LeanLife Health bolsters team with new operations manager

The company said it had brought on Glenn Nichols who will lead the buildout of LeanLife's production facility
pills
LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds — one of the richest plant sources of this essential fatty acid.

LeanLife Health Inc (CSE:LLP) announced Thursday that it boosting its team and has hired an operations manager.

The company said it had appointed Glenn Nichols who will lead the buildout of LeanLife's production facility. 

"Nichols's involvement is part of a company-wide reboot, where every position and expenditure is evaluated for its strategic benefit. He brings more than 15 years of product and operations management experience, having worked with large multicompany teams, combined with a strong automation engineering background," said the company in a release. 

READ: LeanLife Health names Jason Tong as new finance chief

Over the past number of years, Nichols has had a number of roles in the nutraceutical market, bringing a manufacturing plant operational while automating several of its complex processes to maximize efficiencies, reduce labour requirements, and improve product quality and consistency.

The company said one of his primary strengths is his ability to identify problems with current or planned products and processes. His creative solutions have resulted in him being named in several patents granted, pending or in the application stage, for every company he has worked with over the past 18 years.

"LeanLife looks forward to benefiting from Mr. Nichols's expertise as it prepares a clear path to fulfilling its original mandate of providing a shelf-stable omega-3 product to meet the growing demand," said Stan Lis, chief executive officer in a statement.

"I look forward to applying my proven expertise in food production to LeanLife and, in particular, to bringing efficiencies to its processes," said Nichols in a release. 

LeanLife has developed a patented process to isolate omega 3 fatty acids from flax (linen) seeds — one of the richest plant sources of this essential fatty acid.

 

Contact Katie Lewis at [email protected]

View full LLP profile View Profile

LeanLife Health Timeline

Newswire
February 07 2019

Related Articles

lung in x-ray
February 25 2019
The company has been developing a treatment for chronic lung disease in-house and has partnered with an Australian group to develop a drug for rare liver and lung complaints
scientist in lab
December 18 2018
VAL401 is ValiRx’s most advanced compound, with earlier trial results suggesting it can improve quality of life and chances of survival of lung cancer patients
A paper rocket is ready to launch on a surgeon's scissors
March 28 2019
The company hopes to improve its share price with ADAPT technology successes.
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use